{"id":"https://openalex.org/W2336685181","doi":"https://doi.org/10.1158/1557-3265.hemmal14-b10","title":"Abstract B10: Studying BCL-2 dependence using BH3 profiling in a phase 2 clinical trial of ABT-199 in acute myeloid leukemia.","display_name":"Abstract B10: Studying BCL-2 dependence using BH3 profiling in a phase 2 clinical trial of ABT-199 in acute myeloid leukemia.","publication_year":2015,"publication_date":"2015-08-19","ids":{"openalex":"https://openalex.org/W2336685181","doi":"https://doi.org/10.1158/1557-3265.hemmal14-b10","mag":"2336685181"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.hemmal14-b10","doi":"https://doi.org/10.1158/1557-3265.hemmal14-b10","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.hemmal14-b10","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067250104","display_name":"Leah J. Hogdal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leah Hogdal","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066196706","display_name":"Brenda Chyla","orcid":"https://orcid.org/0000-0003-2594-9696","observed_orcids":["https://orcid.org/0000-0003-2594-9696"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda Chyla","raw_affiliation_strings":["2AbbVie Inc, North Chicago, IL,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie Inc, North Chicago, IL,","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087951266","display_name":"Evelyn Mary McKeegan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evelyn McKeegan","raw_affiliation_strings":["2AbbVie Inc, North Chicago, IL,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie Inc, North Chicago, IL,","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088427493","display_name":"Joel D. Leverson","orcid":"https://orcid.org/0000-0003-1162-724X","observed_orcids":["https://orcid.org/0000-0003-1162-724X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Leverson","raw_affiliation_strings":["2AbbVie Inc, North Chicago, IL,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie Inc, North Chicago, IL,","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091254943","display_name":"Jalaja Potluri","orcid":"https://orcid.org/0000-0002-1146-8253","observed_orcids":["https://orcid.org/0000-0002-1146-8253"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jalaja Potluri","raw_affiliation_strings":["2AbbVie Inc, North Chicago, IL,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie Inc, North Chicago, IL,","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059315880","display_name":"Rod A. Humerickhouse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rod Humerickhouse","raw_affiliation_strings":["2AbbVie Inc, North Chicago, IL,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie Inc, North Chicago, IL,","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112409391","display_name":"Mack H. Mabry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mabry Mack","raw_affiliation_strings":["3AbbVie Inc, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AbbVie Inc, Redwood City, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel DeAngelo","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051795460","display_name":"Ilene A Galinsky","orcid":"https://orcid.org/0000-0002-9158-5061","observed_orcids":["https://orcid.org/0000-0002-9158-5061"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ilene Galinsky","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Stone","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022857112","display_name":"Anthony G. Letai","orcid":"https://orcid.org/0000-0002-1993-9013","observed_orcids":["https://orcid.org/0000-0002-1993-9013"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Letai","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"17_Supplement","first_page":"B10","last_page":"B10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.12409999966621399,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8519999980926514},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.871999979019165},{"id":"https://openalex.org/keywords/bcl-2-dependence","display_name":"BCL-2 dependence","score":0.9710000157356262},{"id":"https://openalex.org/keywords/bh3-profiling","display_name":"BH3 profiling","score":0.9929999709129333},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.7129999995231628},{"id":"https://openalex.org/keywords/cytochrome-c-release","display_name":"cytochrome c release","score":0.9520000219345093},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7720000147819519},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.9660000205039978},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.4659999907016754},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.753000020980835},{"id":"https://openalex.org/keywords/bak","display_name":"Bak","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.7519999742507935},{"id":"https://openalex.org/keywords/bcl-w","display_name":"Bcl-w","score":0.8840000033378601},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5680000185966492},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.49799999594688416},{"id":"https://openalex.org/keywords/bone-marrow-aspirate","display_name":"bone marrow aspirate","score":0.6880000233650208},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7488162517547607},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5570199489593506},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5341811180114746},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5175535082817078},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4891655743122101},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4839904308319092},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.4550541043281555},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4291347563266754},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36597299575805664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3595901131629944},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2786545753479004},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.18816789984703064},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10797488689422607}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.hemmal14-b10","doi":"https://doi.org/10.1158/1557-3265.hemmal14-b10","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.hemmal14-b10","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W68676002","https://openalex.org/W2512593159","https://openalex.org/W7096562014","https://openalex.org/W2221401096","https://openalex.org/W2102461774","https://openalex.org/W2338715855","https://openalex.org/W1123756285","https://openalex.org/W2016398606","https://openalex.org/W2276563970","https://openalex.org/W65177702"],"abstract_inverted_index":{"Abstract":[0],"Most":[1],"patients":[2,236,341],"with":[3,173,213,237,483],"acute":[4,547],"myeloid":[5,548],"leukemia":[6,60],"(AML)":[7],"become":[8],"resistant":[9],"to":[10,20,26,36,38,81,113,126,176,264,309,349,368,381,399,563],"chemotherapy":[11],"at":[12,207,449],"some":[13],"point":[14],"in":[15,32,98,157,161,215,217,231,241,244,330,411,452,489,505,538,546],"their":[16,21],"course":[17],"and":[18,43,52,75,101,139,179,312,318,345,353,374,401],"succumb":[19],"disease.":[22],"It":[23],"is":[24,49,110,240,390,408,446],"necessary":[25],"prevent":[27],"chemo-resistance":[28],"or":[29,197],"enhance":[30],"chemosensitivity":[31],"a":[33,39,44,50,111,120,162,228,479,539],"selective":[34,53],"fashion":[35],"lead":[37],"higher":[40],"cure":[41],"rate":[42,142],"lower":[45],"toxic":[46],"burden.":[47],"ABT-199":[48,82,205,239,301,362,389,428,445,470,482,492,545],"potent":[51],"inhibitor":[54],"of":[55,119,129,136,143,183,234,262,283,326,425,462,481,544,553],"the":[56,115,133,141,168,208,232,313,323,340,347,350,369,382,417,434,450,458,463,494,554],"anti-apoptotic,":[57],"protein":[58,171],"B-cell":[59],"/lymphoma":[61],"2":[62,541],"(BCL-2).":[63],"We":[64,90,274,356],"have":[65,91,364,472],"previously":[66],"shown":[67],"that":[68,210,221,252,276,291,358,388,406,444,457,467,478],"AML":[69,235,277,293,465,500],"cell":[70,99,121,159,164,503],"lines,":[71],"primary":[72,76,102,278],"patient":[73,103,294],"samples":[74,104,295],"xenografts":[77],"are":[78,155],"very":[79],"sensitive":[80],"treatment":[83,233,344,471],"(Pan":[84],"et":[85],"al.":[86],"2014.":[87],"Cancer":[88,575],"Discovery).":[89],"also":[92,150,420],"measured":[93,255,415],"dependence":[94,254,534],"on":[95,194,299,343,558],"BCL-2-mediated":[96],"apoptosis":[97,303],"lines":[100],"using":[105,201,535],"BH3":[106,108,134,147,202,222,257,267,333,440,536],"profiling.":[107],"profiling":[109,148,203,223,258,441,537],"method":[112],"determine":[114],"mitochondrial":[116],"priming":[117,413,460],"level":[118,461],"by":[122,256,304,416],"exposing":[123],"cellular":[124],"mitochondria":[125,451],"standardized":[127],"amounts":[128,282],"peptides":[130,379],"derived":[131],"from":[132,307,397,431],"domains":[135],"BH3-only":[137,170],"proteins":[138,316],"determining":[140],"cytochrome":[144,184,284],"c":[145,185,285],"release.":[146],"can":[149],"identify":[151],"which":[152,497],"anti-apoptotic":[153,192],"species":[154],"critical":[156],"mediating":[158],"death":[160,504],"given":[163],"type.":[165],"For":[166],"instance,":[167],"BAD":[169,187,287],"binds":[172],"high":[174],"affinity":[175],"BCL-2,":[177,195],"BCL-XL":[178,196,372,400],"BCL-W.":[180,198],"Thus,":[181],"release":[182,280],"following":[186,286,469],"peptide":[188,288],"incubation":[189],"suggests":[190,387,477],"an":[191,365,409,422],"dependency":[193],"Mitochondrial":[199],"studies":[200],"demonstrate":[204],"activity":[206],"mitochondrion":[209],"correlates":[211],"well":[212],"cytotoxicity":[214],"our":[216,248,439],"vitro":[218],"assays":[219],"suggesting":[220,290,421],"may":[224,259,486],"prove":[225],"useful":[226],"as":[227,393,414,427],"predictive":[229,261],"biomarker":[230],"ABT-199.":[238],"clinical":[242,506,542],"development":[243],"relapsed/refractory":[245],"AML.":[246],"Since":[247],"pre-clinical":[249],"results":[250],"suggest":[251],"BCL-2":[253,308,398,432,533],"be":[260,487],"sensitivity":[263],"ABT-199,":[265],"we":[266,332,404,455],"profiled":[268,334],"pre-treatment":[269,383],"bone":[270,335],"marrow":[271,336],"aspirate":[272],"samples.":[273,384],"found":[275,357],"cells":[279,501],"varying":[281],"incubation,":[289],"different":[292,297],"possess":[296],"dependencies":[298],"BCL-2.":[300],"promotes":[302],"displacing":[305],"BIM":[306,354,396,418,430],"other":[310,484],"anti-apoptotics":[311],"pro-apoptotic":[314,436,495],"effector":[315],"BAX":[317],"BAK.":[319],"To":[320],"test":[321],"if":[322],"proposed":[324],"mechanism":[325,424],"action":[327,426],"was":[328],"active":[329],"vivo,":[331],"aspirates":[337],"collected":[338],"while":[339],"were":[342],"analyzed":[346],"response":[348,367],"NOXA,":[351],"HRK":[352,370],"peptides.":[355],"blasts":[359,466],"isolated":[360],"after":[361],"exposure":[363],"increased":[366,473],"(measures":[371,376],"dependence)":[373,378],"NOXA":[375],"MCL-1":[377],"compared":[380],"This":[385,476],"finding":[386],"working":[391],"on-target":[392,423,448],"it":[394],"displaces":[395,429],"MCL-1.":[402],"Furthermore,":[403,454],"find":[405,456],"there":[407],"increase":[410],"overall":[412,435,459,474],"peptide,":[419],"increasing":[433],"reserve.":[437],"Briefly,":[438],"data":[442],"show":[443],"acting":[447],"vivo.":[453],"residual":[464],"remain":[468],"priming.":[475],"combination":[480],"agents":[485],"beneficial":[488],"AML,":[490],"since":[491],"increases":[493],"reserve":[496],"might":[498],"push":[499],"towards":[502],"settings.":[507],"Citation":[508],"Format:":[509],"Leah":[510],"Hogdal,":[511],"Brenda":[512],"Chyla,":[513],"Evelyn":[514],"McKeegan,":[515],"Joel":[516],"Leverson,":[517],"Jalaja":[518],"Potluri,":[519],"Rod":[520],"Humerickhouse,":[521],"Mabry":[522],"Mack,":[523],"Daniel":[524],"DeAngelo,":[525],"Ilene":[526],"Galinsky,":[527],"Richard":[528],"Stone,":[529],"Anthony":[530],"Letai.":[531],"Studying":[532],"phase":[540],"trial":[543],"leukemia.":[549],"[abstract].":[550],"In:":[551],"Proceedings":[552],"AACR":[555],"Special":[556],"Conference":[557],"Hematologic":[559],"Malignancies:":[560],"Translating":[561],"Discoveries":[562],"Novel":[564],"Therapies;":[565],"Sep":[566],"20-23,":[567],"2014;":[568],"Philadelphia,":[569],"PA.":[570],"Philadelphia":[571],"(PA):":[572],"AACR;":[573],"Clin":[574],"Res":[576],"2015;21(17":[577],"Suppl):Abstract":[578],"nr":[579],"B10.":[580]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}